| |
| |
|
| Insider
Information: |
Horowitz Zebulun D |
| Relationship: |
SVP - Chief Medical Of... |
| City: |
East Brunswick, |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
144,683 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
144,683 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Savient Pharmaceuticals Inc |
SVNTQ |
SVP - Chief Medical Of... |
2009-02-17 |
144,683 |
2005-02-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SVNTQ |
Savient Pharmaceuticals I... |
SVP - Chief Medical Officer |
• – – |
2009-02-17 |
4 |
AS |
$5.87 |
$31,555 |
D/D |
(5,380) |
144,683 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
SVP - Chief Medical Officer |
• – – |
2009-02-17 |
4/A |
AS |
$5.87 |
$31,555 |
D/D |
(5,380) |
144,683 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
SVP - Chief Medical Officer |
• – – |
2008-12-09 |
4 |
AS |
$4.82 |
$24,391 |
D/D |
(5,050) |
150,063 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
SVP - Chief Medical Officer |
• – – |
2008-12-08 |
4 |
A |
$4.53 |
$52,847 |
D/D |
11,666 |
155,113 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
SVP - Chief Medical Officer |
• – – |
2008-11-04 |
4 |
D |
$5.17 |
$41,096 |
D/D |
(7,949) |
143,447 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
SVP - Chief Medical Officer |
• – – |
2008-11-04 |
4 |
A |
$5.17 |
$90,475 |
D/D |
17,500 |
151,396 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
SVP, Chief Medical Officer |
• – – |
2008-04-14 |
4 |
AS |
$19.05 |
$72,094 |
D/D |
(3,785) |
133,896 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
SVP, Chief Medical Officer |
• – – |
2008-03-05 |
4 |
A |
$23.01 |
$379,665 |
D/D |
16,500 |
145,175 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
SVP, Chief Medical Officer |
• – – |
2008-03-05 |
4 |
D |
$23.42 |
$175,521 |
D/D |
(7,494) |
137,681 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
SVP, Chief Medical Officer |
• – – |
2008-02-15 |
4 |
AS |
$19.95 |
$87,844 |
D/D |
(4,403) |
128,675 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
SVP, Chief Medical Officer |
• – – |
2008-02-04 |
4 |
OE |
$4.31 |
$21,550 |
D/D |
5,000 |
138,078 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
SVP, Chief Medical Officer |
• – – |
2008-02-04 |
4 |
S |
$19.86 |
$99,306 |
D/D |
(5,000) |
133,078 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
SVP, Chief Medical Officer |
• – – |
2008-02-01 |
4 |
S |
$19.56 |
$97,791 |
D/D |
(5,000) |
133,078 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
SVP, Chief Medical Officer |
• – – |
2008-02-01 |
4 |
OE |
$2.52 |
$12,600 |
D/D |
5,000 |
138,078 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
SVP, Chief Medical Officer |
• – – |
2008-01-22 |
4 |
OE |
$2.52 |
$12,600 |
D/D |
5,000 |
138,078 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
SVP, Chief Medical Officer |
• – – |
2008-01-22 |
4 |
S |
$20.21 |
$101,061 |
D/D |
(5,000) |
133,078 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
SVP, Chief Medical Officer |
• – – |
2008-01-18 |
4 |
S |
$20.67 |
$103,337 |
D/D |
(5,000) |
133,078 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
SVP, Chief Medical Officer |
• – – |
2008-01-18 |
4 |
OE |
$2.52 |
$12,600 |
D/D |
5,000 |
138,078 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
SVP, Chief Medical Officer |
• – – |
2008-01-17 |
4 |
OE |
$2.52 |
$12,600 |
D/D |
5,000 |
138,078 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
SVP, Chief Medical Officer |
• – – |
2008-01-17 |
4 |
S |
$20.44 |
$102,198 |
D/D |
(5,000) |
133,078 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
SVP, Chief Medical Officer |
• – – |
2008-01-16 |
4 |
S |
$20.64 |
$103,218 |
D/D |
(5,000) |
133,078 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
SVP, Chief Medical Officer |
• – – |
2008-01-16 |
4 |
OE |
$2.52 |
$12,600 |
D/D |
5,000 |
138,078 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
SVP, Chief Medical Officer |
• – – |
2008-01-15 |
4 |
OE |
$2.52 |
$12,600 |
D/D |
5,000 |
138,078 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
SVP, Chief Medical Officer |
• – – |
2008-01-15 |
4 |
S |
$21.46 |
$107,302 |
D/D |
(5,000) |
133,078 |
0 |
- |
|
| SVNTQ |
Savient Pharmaceuticals I... |
SVP, Chief Medical Officer |
• – – |
2008-01-14 |
4 |
S |
$21.77 |
$108,846 |
D/D |
(5,000) |
133,078 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
